Your browser doesn't support javascript.
loading
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, N C; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, A; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W.
Afiliación
  • Elander NO; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Aughton K; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Ghaneh P; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Neoptolemos JP; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Palmer DH; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Cox TF; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Campbell F; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Costello E; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Halloran CM; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Mackey JR; Cross Cancer Institute and University of Alberta, Edmonton, Canada.
  • Scarfe AG; Cross Cancer Institute and University of Alberta, Edmonton, Canada.
  • Valle JW; University of Manchester/The Christie NHS Foundation Trust, Manchester, UK.
  • McDonald AC; The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Carter R; Glasgow Royal Infirmary, Glasgow, UK.
  • Tebbutt NC; Austin Health, Melbourne, VIC, Australia.
  • Goldstein D; Prince of Wales hospital and Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Shannon J; Nepean Cancer Centre and University of Sydney, Camperdown, NSW, Australia.
  • Dervenis C; The Agia Olga Hospital, Athens, Greece.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Deakin M; University Hospital, North Staffordshire, Staffordshire, UK.
  • Charnley RM; Freeman Hospital, Newcastle upon Tyne, UK.
  • Anthoney A; St James's University Hospital, Leeds, UK.
  • Lerch MM; Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.
  • Mayerle J; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Oláh A; The Petz Aladar Hospital, Gyor, Hungary.
  • Büchler MW; Department of Surgery, University of Heidelberg, Heidelberg, Germany.
  • Greenhalf W; Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK. greenhaf@liv.ac.uk.
Br J Cancer ; 118(8): 1084-1088, 2018 04.
Article en En | MEDLINE | ID: mdl-29523831
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Biomarcadores de Tumor / Proteínas Supresoras de Tumor / DCMP Desaminasa Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Biomarcadores de Tumor / Proteínas Supresoras de Tumor / DCMP Desaminasa Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido